Prognostic signature inflation in gynecologic oncology: biomarker proliferation beyond clinical translation.

Risk stratification for single-agent chemoresistance in low-risk gestational trophoblastic neoplasia: a multicenter retrospective study.

Balancing fertility potential and oncologic and obstetric risks: a vignette study on decision-making in fertility-sparing surgery for early-stage cervical cancer.

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753

Correspondence on "Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis" by Kim et al.

Expanding HER2-targeted therapeutic strategies in endometrial cancer.

Prognostic signature inflation in gynecologic oncology: biomarker proliferation beyond clinical translation.

Risk stratification for single-agent chemoresistance in low-risk gestational trophoblastic neoplasia: a multicenter retrospective study.

Balancing fertility potential and oncologic and obstetric risks: a vignette study on decision-making in fertility-sparing surgery for early-stage cervical cancer.

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753

Correspondence on "Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis" by Kim et al.

Expanding HER2-targeted therapeutic strategies in endometrial cancer.